These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 803123)

  • 1. Familial hyperlipoproteinemia and gallstones.
    Singh A
    Can Med Assoc J; 1975 Oct; 113(8):733-5. PubMed ID: 803123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Familial incidence of gallstones].
    Nürnberg D; Berndt H; Pannwitz H
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1059-63. PubMed ID: 2737096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid kinetics in relation to sex, serum lipids, body weights, and gallbladder disease in patients with various types of hyperlipoproteinemia;
    Einarsson K; Hellström K; Kallner M
    J Clin Invest; 1974 Dec; 54(6):1301-11. PubMed ID: 4373491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic epidemiology of cholelithiasis. A case-control study of a population].
    Leoci C; Chiloiro M; Guerra V; Misciagna G
    Minerva Gastroenterol Dietol; 1991; 37(1):35-9. PubMed ID: 1873328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipid profile in gallstone patients from North India.
    Saraya A; Irshad M; Gandhi BM; Tandon RK
    Trop Gastroenterol; 1995; 16(4):16-21. PubMed ID: 8854950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An increased familial frequency of gallstones.
    Gilat T; Feldman C; Halpern Z; Dan M; Bar-Meir S
    Gastroenterology; 1983 Feb; 84(2):242-6. PubMed ID: 6848404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phenotype change in hyperlipoproteinemias].
    Meincke H
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):236-9. PubMed ID: 4085393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of serum lipid profile and gallstone disease.
    Aulakh R; Mohan H; Attri AK; Kaur J; Punia RP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):308-12. PubMed ID: 17883052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of slow-release bezafibrate on serum lipids, lipoproteins, apolipoproteins, and postheparin lipolytic activities in patients with type IV and type V hypertriglyceridemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(3):331-40. PubMed ID: 2743372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THe influence of aging upon gallstones--changes in serum lipids, lithogenesis of bile and cross-sectional views of stones with age.
    Kajiyama G; Fujiyama M; Yamada K; Horiuchi I; Miyoshi A
    Hiroshima J Med Sci; 1981 Sep; 30(3):165-74. PubMed ID: 7298367
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for symptomatic gallstones in patients with liver cirrhosis: a case-control study.
    Acalovschi M; Blendea D; Feier C; Letia AI; Ratiu N; Dumitrascu DL; Veres A
    Am J Gastroenterol; 2003 Aug; 98(8):1856-60. PubMed ID: 12907344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
    Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial disorders of lipid metabolism in childhood].
    Herrmann W; Biermann J
    Z Arztl Fortbild (Jena); 1986; 80(17):725-8. PubMed ID: 3811401
    [No Abstract]   [Full Text] [Related]  

  • 17. [Matched investigation of risk factors in coronary heart patients with gallstones].
    Zhou X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1990 Feb; 11(1):5-8. PubMed ID: 2322944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of primary hyperlipoproteinemia type IV. An analysis of 86 patients].
    Kusić M; Gavrilović M; Mihajlović M; Marković N
    Zb Vojnomed Akad; 1981; 23():15-9. PubMed ID: 6963834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).
    Hepatology; 1988; 8(4):907-13. PubMed ID: 3391520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.